NCT02902380View on ClinicalTrials.gov

The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 27, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Spinal Stenosis
Interventions
DRUG

dexmedetomidine group

dexmedetomidine infusion (0.4 mcg/kg/h) from immediately after anesthetic induction to end of surgery

DRUG

control group

0.9% saline infusion

Trial Locations (1)

03722

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02902380 - The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery | Biotech Hunter | Biotech Hunter